863 Pill - white capsule-shape, 18mm
Pill with imprint 863 is White, Capsule-shape and has been identified as Topiramate Extended-Release 25 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Topiramate is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Seizure Prevention; Seizures; Epilepsy and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 863
Topiramate Extended-Release
- Imprint
- 863
- Strength
- 25 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 68382-0863
- Inactive Ingredients
-
alcohol,
ammonia,
butyl alcohol,
microcrystalline cellulose,
ethylcellulose,
ferrosoferric oxide,
gelatin,
hydrogenated castor oil,
hypromelloses,
isopropyl alcohol,
polyethylene glycol,
potassium hydroxide,
povidone,
propylene glycol,
shellac,
sodium lauryl sulfate,
magnesium silicate,
titanium dioxide,
triethyl citrate,
water
Note: Inactive ingredients may vary.
Related images for "863"
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,313)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
- Topiramate drug information
- Topiramate (Advanced Reading)
- Topiramate Tablets
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Sprinkle Capsules
- Topiramate Extended-Release Capsules
Other brands
Topamax, Trokendi XR, Topamax Sprinkle, Qudexy XR, ... +2 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.